Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk would violate U.S. antitrust law. Metsera called the arguments “nonsense” ...

CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five ...

With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs.

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

The expiration of ACA tax credits could drive up premiums across marketplace and commercial insurance plans, a Cigna executive warned.

The Supreme Court has made a series of decisions that have implications for healthcare. Below is an overview of these decisions. The Chevron deference In a 6-3 ruling last week, the Supreme Court ...

Kaiser Permanente announced one of the biggest mergers in recent hospital M&A history on Wednesday. The California-based integrated health system, which owns 39 hospitals, said it plans to acquire ...

Cortica, a provider for children with autism and neurodivergent conditions, last week secured $80 million in funding co-led by Morgan Health and Nexus NeuroTech Ventures. San Diego, California-based ...

The nation’s independent cardiology practices are facing serious challenges, such as financial pressures, rising competition and fragmented technology. These struggles have left many practices with no ...

The use of AI in healthcare has evolved quite a bit over the past few years — with many healthcare organizations transitioning from a state of cautious experimentation to more serious attempts at ...

Syndax Pharmaceuticals has won FDA approval for a drug addressing advanced cases of acute leukemia carrying a particular genetic signature that leads to an aggressive form of the disease. The ...

The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary disease ...